PROGRAM
8:30 hrs – Registration & welcome coffee
9:00 hrs – Introduction
Session 1: Updates from new studies: TDM in clinical practice
9:10 hrs – Updates from two randomized controlled studies TODORA and ADDORA using TDM in clinical practice in patients with rheumatic diseases
Drs. Sadaf Atiqi, Reade, the Netherlands
9:30 hrs – TDM in IBD: Insights from Prospective Clinical Trials
Dr. Mark Löwenberg MD, AmsterdamUMC, the Netherlands
9:50 hrs – TDM updates in dermatology
Dr. Teresa Tsakok, King’s College London, United Kingdom
10:10 hrs – Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A
Dr Corien Eckhardt, UMC Utrecht, the Netherlands
10:30 hrs – pdates from the SUPERNEXT study: personalised extended interval dosing of natalizumab in patients with multiple sclerosis
Drs Liza Gelissen, Amsterdam UMC, the Netherlands
10:50 hrs – Panel discussion
11.00 hrs – Coffee break
Session 2: Developments in PK modelling in TDM
11:30 hrs – Model-informed precision dosing in TDM of biologics
Drs Stefan van den Berg, Sanquin, the Netherlands
11:50 hrs – Using artificial intelligence in TDM models
Drs Alexander Janssen, Amsterdam UMC, the Netherlands
12:10 hrs – Clinical pharmacology of infliximab in pediatrics
Dr Tim Preijers, Erasmus MC, the Netherlands
12:30 hrs – Panel discussion
12:45 hrs – Lunch
Session 3: Implementation of TDM in clinical practice
13:45 hrs – Patient perspective in TDM of biologics
Drs Suzanne Anjie, AmsterdamUMC, the Netherlands and Drs Maureen Leeuw, Reade, the Netherlands
14:00 hrs – How to implement home-monitoring
TBC
14:15 hrs – Implementation of home-monitoring of biologics in neurology
Dr. Zoé van Kempen, Amsterdam UMC, the Netherlands
14:30 hrs – Panel discussion
14:45 hrs – Coffee break
Session 4: Future of TDM
15:15 hrs – Update and future of TDM of biologics from Norway
Prof. Dr. Espen A Haavardsholm, University of Oslo/Diakonhjemmet Hospital, Norway
15:45 hrs – The future of TDM of biologics in different fields
5 minutes pitches followed by panel discussion
Overview Gastrointestinal field
Dr Mark Löwenberg, AmsterdamUMC, the Netherlands
Overview Rheumatology field
Prof. Dr. Gerg-Jan Wolbink
Overview Dermatology field
Dr. Teresa Tsakok, King’s College London, United Kingdom
Overview Neurology field
Prof. Dr. Joep Killestein, AmsterdamUMC, the Netherlands
Overview Oncology field
Dr. Dirk-Jan Moes, LUMC, the Netherlands
16:45 hrs – FAREWELL DRINKS and network reception
